The 20-Year Voyage Aboard the Journal of Alzheimer's Disease: Docking at ‘Type 3 Diabetes’, Environmental/Exposure Factors, Pathogenic Mechanisms, and Potential Treatments-Reference-Cited by-同舟云学术

The 20-Year Voyage Aboard the Journal of Alzheimer's Disease: Docking at ‘Type 3 Diabetes’, Environmental/Exposure Factors, Pathogenic Mechanisms, and Potential Treatments

Published:2018-03-13 Issue:3 Volume:62 Page:1381-1390
ISSN:1387-2877
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

de la Monte Suzanne M.¹,Tong Ming¹,Wands Jack R.¹

Affiliation:

1. Departments of Neurology, Pathology (Neuropathology), Neurosurgery, and Medicine, Rhode Island Hospital and The Alpert Medical School of Brown University, Providence, RI, USA

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference93 articles.

1. Cerebrovascular pathology contributes to the heterogeneity of Alzheimer’s disease;Etiene;J Alzheimers Dis,1998

2. Is the risk of Alzheimer’s disease and dementia declining?;Langa;Alzheimers Res Ther,2015

3. Oxygen free radical injury is sufficient to cause some Alzheimer-type molecular abnormalities in human CNS neuronal cells;de la Monte;J Alzheimers Dis,2000

4. Transient hypoxia causes Alzheimer-type molecular and biochemical abnormalities in cortical neurons: Potential strategies for neuroprotection;Chen;J Alzheimers Dis,2003

5. Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer’s disease;de la Monte;J Alzheimers Dis,2006

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of antidiabetic agents on platelet characteristics with implications in Alzheimer's disease: Mendelian randomization and colocalization study;Heliyon;2024-05

2. Characterization of preclinical Alzheimer’s disease model: spontaneous type 2 diabetic cynomolgus monkeys with systemic pro-inflammation, positive biomarkers and developing AD-like pathology;Alzheimer's Research & Therapy;2024-03-08

3. DPP-4 inhibition by linagliptin ameliorates age-related mild cognitive impairment by regulating microglia polarization in mice;Experimental Neurology;2024-03

5. Metformin: The Winding Path from Understanding Its Molecular Mechanisms to Proving Therapeutic Benefits in Neurodegenerative Disorders;Pharmaceuticals;2023-12-11